(LMNR) Limoneira - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5327461043
LMNR: Lemons, Avocados, Oranges, Citrus, Wine Grapes
Limoneira Company (NASDAQ:LMNR) is a leading agribusiness and real estate development firm with operations in the United States and internationally. Established in 1893 and headquartered in Santa Paula, California, the company specializes in the cultivation, processing, and marketing of lemons, avocados, oranges, and other specialty citrus fruits. Its operations are divided into four segments: Fresh Lemons, Lemon Packing, Avocados, and Other Agribusiness. The companys agricultural activities span multiple regions, including Ventura, San Luis Obispo, and San Bernardino Counties in California; Jujuy, Argentina; Yuma County, Arizona; and La Serena, Chile. Beyond citrus, Limoneira grows avocados in Ventura County and oranges in Tulare County, California, along with wine grapes and other crops. The company also engages in real estate development, renting residential and commercial properties, and leasing agricultural land. Additionally, Limoneira operates organic recycling programs, provides farm management services, and develops land for multi-family housing and single-family homes. Its products are sold directly to food service, wholesale, and retail customers, as well as to third-party packing houses and wine producers.
Based on the provided data, Limoneiras stock is expected to face resistance at $23.65 (SMA 50) and support at $22.00 (current price level) over the next three months. The relatively high P/E ratio of 56.68 and forward P/E of 204.08 suggest elevated valuations, potentially limiting upside unless earnings improve. The low ATR of 0.73 indicates reduced volatility, pointing to a possible sideways trading range. With a return on equity (RoE) of 4.01%, profitability remains modest. Overall, the 3-month outlook appears cautious, with the stock likely consolidating near current levels absent significant catalysts.
Additional Sources for LMNR Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
LMNR Stock Overview
Market Cap in USD | 287m |
Sector | Consumer Defensive |
Industry | Farm Products |
GiC Sub-Industry | Agricultural Products & Services |
IPO / Inception | 2001-11-08 |
LMNR Stock Ratings
Growth Rating | 34.1 |
Fundamental | 6.59 |
Dividend Rating | 35.7 |
Rel. Strength | -25.3 |
Analysts | 3.5/5 |
Fair Price Momentum | 14.10 USD |
Fair Price DCF | 4.82 USD |
LMNR Dividends
Dividend Yield 12m | 1.56% |
Yield on Cost 5y | 2.61% |
Annual Growth 5y | 0.00% |
Payout Consistency | 94.4% |
LMNR Growth Ratios
Growth Correlation 3m | -93.2% |
Growth Correlation 12m | 14.4% |
Growth Correlation 5y | 62.9% |
CAGR 5y | 6.87% |
CAGR/Max DD 5y | 0.15 |
Sharpe Ratio 12m | -0.12 |
Alpha | -21.27 |
Beta | 0.448 |
Volatility | 39.07% |
Current Volume | 118.5k |
Average Volume 20d | 65.1k |
As of April 18, 2025, the stock is trading at USD 16.02 with a total of 118,521 shares traded.
Over the past week, the price has changed by -1.81%, over one month by -14.74%, over three months by -30.22% and over the past year by -14.53%.
Neither. Based on ValueRay Fundamental Analyses, Limoneira is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 6.59 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LMNR as of April 2025 is 14.10. This means that LMNR is currently overvalued and has a potential downside of -11.99%.
Limoneira has received a consensus analysts rating of 3.50. Therefor, it is recommend to hold LMNR.
- Strong Buy: 0
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, LMNR Limoneira will be worth about 15.2 in April 2026. The stock is currently trading at 16.02. This means that the stock has a potential downside of -4.93%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 27 | 68.5% |
Analysts Target Price | 24 | 49.8% |
ValueRay Target Price | 15.2 | -4.9% |